Empresa
Sobre Nosotros
Nuestro Equipo
Descubrimientos
Programas
Publicaciones
Seleccionadas
Todas
EN
Contacto
Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis
Galectin-1 is essential for efficient liver regeneration following hepatectomy
Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation
Impact of human galectin-1 binding to saccharide ligands on dimer dissociation kinetics and structure
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
Ligand-mediated Galectin-1 endocytosis prevents intraneural H2O2 production promoting F-actin dynamics reactivation and axonal re-growth
Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer
Lack of galectin-3 increases Jagged1/Notch activation in bone marrow-derived dendritic cells and promotes dysregulation of T helper cell polarization
